Pablo G. Legorreta
CEO, Chairman of the Board, Director · Royalty Pharma plc
Individual
- 2025
- Aug 7, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pablo G. Legorreta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M in RPRX purchases and sales in the last 12 months
- Christopher Hite - $27.36M in RPRX purchases and sales in the last 12 months
- George W. Lloyd - $9.57M in RPRX purchases and sales in the last 12 months
- Marshall Urist - $7.01M in RPRX purchases and sales in the last 12 months
- Gregory Norden - $161K in RPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pablo G. Legorreta?
Pablo G. Legorreta is a corporate insider, tracked as CEO, Chairman of the Board, Director of Royalty Pharma plc (RPRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pablo G. Legorreta submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
